Protara Therapeutics Inc (TARA)

07:35 AM

Cantor Fitzgerald Initiates Coverage on Protara Therapeutics With Overweight Rating -March 14, 2025 at 07:33 am EDT - Marketscreener.com

07:35 AM

01:18 AM

Analysts Set Expectations for TARA Q1 Earnings - Defense World

01:18 AM

Mar 12, 2025

Protara Therapeutics (NASDAQ:TARA) Coverage Initiated by Analysts at Lifesci Capital - Defense World

Mar 12, 2025

Mar 11, 2025

LifeSci Capital Initiates Coverage of Protara Therapeutics (TARA) with Outperform Recommendation - Nasdaq

Mar 11, 2025

Mar 10, 2025

HC Wainwright Issues Positive Forecast for TARA Earnings - Defense World

Mar 10, 2025

Mar 09, 2025

What is HC Wainwright’s Forecast for TARA FY2029 Earnings? - Defense World

Mar 09, 2025

Mar 09, 2025

Protara Therapeutics’ (TARA) Buy Rating Reiterated at HC Wainwright - Defense World

Mar 09, 2025

Mar 06, 2025

Protara Therapeutics’ TARA-002 Shows Promising Efficacy and Safety in HR-NMIBC, Earning Buy Rating - TipRanks

Mar 06, 2025

Mar 06, 2025

H.C. Wainwright maintains Buy rating on Protara stock, $23 target By Investing.com - Investing.com UK

Mar 06, 2025

Mar 06, 2025

Protara Therapeutics (NASDAQ:TARA) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Mar 06, 2025

Mar 06, 2025

Protara Therapeutics: Q4 Earnings Snapshot - Midland Daily News

Mar 06, 2025

Mar 05, 2025

Protara Therapeutics Reports Progress and Financial Results - TipRanks

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics shares rise on narrower Q4 loss By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics shares rise on narrower Q4 loss - Investing.com

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics reports Q4 EPS (48c) vs (90c) last year - TipRanks

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics: Q4 Earnings Snapshot -March 05, 2025 at 08:21 am EST - Marketscreener.com

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - TradingView

Mar 05, 2025

Mar 05, 2025

Can Protara's 72% Response Rate in Bladder Cancer Trial Transform Treatment Landscape? - StockTitan

Mar 05, 2025

Mar 05, 2025

Protara Therapeutics (TARA) Projected to Post Quarterly Earnings on Wednesday - Defense World

Mar 05, 2025

Mar 01, 2025

Protara Therapeutics Stock Doubles On Promising Bladder Cancer Trial Data: Retail Buzz Spikes - MSN

Mar 01, 2025

Feb 27, 2025

Protara Therapeutics (NASDAQ:TARA) Stock Price Down 4%Here's What Happened - MarketBeat

Feb 27, 2025

Feb 26, 2025

Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewswire

Feb 26, 2025

Feb 26, 2025

Rare Disease Biotech Protara Sets Investor Presentation: What's Next for TARA Pipeline? - StockTitan

Feb 26, 2025

Feb 25, 2025

Protara Therapeutics (NASDAQ:TARA) Stock Price Down 4% – Should You Sell? - Defense World

Feb 25, 2025

Feb 08, 2025

Certain Pre-Funded warrants of Protara Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2025. - Marketscreener.com

Feb 08, 2025

Feb 08, 2025

Certain Common Warrants of Protara Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-FEB-2025. - Marketscreener.com

Feb 08, 2025

Feb 06, 2025

Protara Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewswire

Feb 06, 2025

Feb 06, 2025

Reviewing Protara Therapeutics (NASDAQ:TARA) and Palisade Bio (NASDAQ:PALI) - Defense World

Feb 06, 2025

Feb 05, 2025

Exclusive Healthcare Insights: Protara Therapeutics Takes Center Stage at Major Oppenheimer Conference - StockTitan

Feb 05, 2025

Feb 05, 2025

Protara Therapeutics, Inc. (NASDAQ:TARA) Sees Significant Drop in Short Interest - MarketBeat

Feb 05, 2025

Jan 29, 2025

Protara Therapeutics (NASDAQ:TARA) vs. Cardiff Oncology (NASDAQ:CRDF) Head-To-Head Review - Defense World

Jan 29, 2025

Jan 14, 2025

Geode Capital Management LLC Purchases 29,514 Shares of Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Jan 14, 2025

Jan 13, 2025

Protara Highlights Recent Updates and Anticipated 2025 Milestones - The Manila Times

Jan 13, 2025

Jan 13, 2025

Protara Therapeutics Reports Positive Data from ADVANCED-2 Trial of TARA-002 and Outlines Key 2025 Milestones - Nasdaq

Jan 13, 2025

Jan 08, 2025

Protara Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025

Dec 27, 2024

Protara Therapeutics, Inc. (NASDAQ:TARA) Sees Large Increase in Short Interest - MarketBeat

Dec 27, 2024

Dec 23, 2024

XTX Topco Ltd Buys New Position in Protara Therapeutics, Inc. (NASDAQ:TARA) - Defense World

Dec 23, 2024

Dec 18, 2024

Velan Capital Investment Management LP Increases Stake in Protara Therapeutics Inc - GuruFocus.com

Dec 18, 2024

Dec 16, 2024

Flatiron-based drug company raises $100M for cancer treatment - Crain's New York Business

Dec 16, 2024

Dec 14, 2024

Protara Therapeutics: Rising From The Ashes (NASDAQ:TARA) - Seeking Alpha

Dec 14, 2024

Dec 11, 2024

Protara Therapeutics Raises $100M in Stock Offering - TipRanks

Dec 11, 2024

Dec 11, 2024

Protara Announces Closing of $100 Million Public Offering - GlobeNewswire

Dec 11, 2024

Dec 11, 2024

SEC Form 424B5 filed by Protara Therapeutics Inc. - Quantisnow

Dec 11, 2024

Dec 11, 2024

Protara Therapeutics Secures Massive $100M Public Offering to Advance TARA-002 Development - StockTitan

Dec 11, 2024